| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2013-05-10 | CT327 (TrkA kinase inhibitor ) | psoriasis vulgaris | 2b | Creabilis (Luxembourg) | Autoimmune diseases – Dermatological diseases |
| 2013-05-08 | Cytovir™ ADV | adenovirus infections in immunosuppressed pediatric patients following bone marrow transplantation. |
1-2 | Cell Medica (UK) | Infectious diseases - Transplantation |
| 2013-05-07 | OPN-305 | renal transplant patients at high risk of delayed graft function | 2 | Opsona Therapeutics (Ireland) | Transplantation |
| 2013-05-07 | ALX-0962 | severe allergic asthma |
preclinical | Ablynx (Belgium) | Allergic diseases - Inflammatory diseases - Respiratory diseases |
| 2013-05-06 | metreleptin (analogue of the human hormone leptin) | lipodystrophy | AstraZeneca (UK) BMS (USA) | Metabolic diseases - Rare diseases | |
| 2013-05-03 | BAY 86-6150 (recombinant factor VIIa (rFVIIa) protein) | patients with hemophilia A or B with inhibitors |
2-3 | Bayer (Germany) | Hematologic diseases - Genetic diseases - Rare diseases |
| 2013-05-02 | dipraglurant | Parkinson's disease |
non clinical study | Addex Therapeutics (Switzerland) | Neurodegenerative diseases - CNS diseases |
| 2013-05-02 | elobixibat | 3 | Ferring Pharmaceuticals (Switzerland) | ||
| 2013-05-01 | ofatumumab | relapsed or previously untreated chronic lymphocytic leukemia | 2 | Genmab (Denmark) | Cancer - Oncology |
| 2013-05-01 | aclidinium bromide (LAMA) and formoterol fumarate (LABA), delivered in the Pressair®(Genuair® outside the USA) inhaler | chronic obstructive pulmonary disease (COPD) | 3 | Forest Laboratories (USA) Almirall (Spain) | Respiratory diseases |
| 2013-04-30 | ADX71441 | alcohol binge drinking |
preclinical data | Addex Therapeutics (Switzerland) | CNS diseases |
| 2013-04-29 | EryDex® (dexamethasone sodium phosphate delivered through autologous erythrocytes) | ataxia telangiectasia |
1 | Erydel (Italy) | Rare diseases |
| 2013-04-29 | TG4040 (MVA-HCV) | chronic hepatitis C | 2 | Transgene (France) | Infectious diseases |
| 2013-04-29 | BL-8020 | hepatitis C |
1-2 | BiolineRx (Israel) | Infectious diseases |
| 2013-04-29 | TM–400 | improvement of hematopoietic stem cell transplantation for patients with hematopoietic cancer | 1-2 | TikoMed (Sweden) | Cancer - Oncology |
| 2013-04-26 | MOR208 | B-cell acute lymphoblastic leukemia (B-ALL) | 2 | Morphosys (Germany) | Cancer - Oncology |
| 2013-04-24 | ADX71441 | Charcot-Marie-Tooth 1A disease | 1 | Addex Therapeutics (Switzerland) | Rare diseases - Genetic diseases - Neurological diseases |
| 2013-04-17 | BL-7040 | inflammatory bowel disease (IBD) |
2 | BioLineRx (Israel) | Inflammatory diseases |
| 2013-04-16 | BI-505 | preclinical | BioInvent (Sweden) | Cancer - Oncology | |
| 2013-04-16 | aclidinium bromide and formoterol fumarate twice daily (BID) delivered in the Genuair® inhaler | chronic obstructive pulmonary disease (COPD) |
3 | Almirall (Spain) Forest Laboratories (USA) | Respiratory diseases |
